| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |